Zentiva N.V. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Zentiva N.V. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Zentiva N.V.. The Group's principal activities are producing, developing and selling of generic pharmaceuticals, including pharmaceutical chemicals, cosmetics and packaging for pharmaceutical products and special purpose equipment and machines for the pharmaceutical industry. The Group's main operations are based on Czech Republic, Slovak Republic, the Baltic states, Romania, Bulgaria, Moldavia and the Commonwealth of independent states. Some branded pharmaceutical products manufactured by the group include: Helicid, Lozap, Torvacard, Simvacard and Ibalgin. On Mar 5, 2007, the Group signed an agreement to acquire 75% of the issued capital of Eczacibasi Generic Pharmaceuticals, a pharmaceutical company in Turkey.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report